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Context
Septoplasty is a common surgical procedure performed to correct the deviated nasal septum.
A clear surgical field is imperative for the success rate of the procedure. It can be achieved
by improving the visualization of the sinonasal structures by optimizing good hemostasis.
Adrenaline local infiltration was commonly used despite its potential risks and complications;
it is still controversial and referred to as surgeon preference. We aimed to study and evaluate
the effect of diluted adrenaline injection in the submucoperichondrial plane in the nasal septum
during nasal surgery in relation to hemodynamic parameters of the patient during the procedure.

Aims

We aimed to study and evaluate the effect of diluted adrenaline injection in the
submucoperichondrial plane in the nasal septum during nasal surgery in relation to
hemodynamic parameters of the patients during the procedure.

Patients and methods

This retrospective single‑center study included patients who underwent septoplasty under
general anesthesia at Al‑Noor Specialist Hospital from 2014 till 2018.

Statistical analysis

Statistical analysis was performed using Statistical Package for Social Science software,
version 21.0.

Results

This study included 223 patients who underwent septoplasty. Males were more prevalent
than females (72.6 vs. 27.4%). The sample included 19.3% patients with diabetes, 17.5%
were hypertensive, 3.6% had cardiac disease, 1.8% had hypothyroidism, and 2.2% had renal
diseases. The mean ± SD of heart rate, systolic blood pressure, diastolic blood pressure,
mean arterial pressure, and oxygen saturation at baseline and after injection for 12 min was
recorded, reflecting no significant changes regarding increasing in all parameters.

Conclusions

Injection of diluted adrenaline (1: 100 000 or 1: 200 000) during septoplasty in relation to
hemodynamic parameters is safe, as there is no increase in heart rate, blood pressure, or
mean arterial pressure after the infiltration in the submucoperichondrial plane regardless of
the patients’ comorbidities.
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Introduction
Septoplasty is one of the most common operations
performed in otorhinolaryngology [1].Good hemostasis
is essential for optimal visualization during septoplasty
as the sinonasal region is a small area that can be filled
with blood quickly even with a small amount and lead
to obscuring of the visual field and limits the approach
for open and close septoplasty [2,3]. Most of the
otolaryngologists advise infiltration of the submucosal
area by local anesthetic containing epinephrine to
obtain the hemostasis and reduce postoperative
pain [4]. In the present study, we aimed to evaluate
and determine the complications that are related to
the effect of using diluted adrenaline injection mixed
with 1% of lidocaine in the submucoperichondrial

plane in nasal septum during nasal surgery in relation
to hemodynamic parameters of the patients including
patients with comorbidity.

Patients and method
A retrospective study was conducted that included
patients who underwent septoplasty under general
anesthesia at Al‑Noor Specialist Hospital, Makkah,
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Saudi Arabia, during the period from 1/1/2014 to
3/12/2018. The protocol of the surgery included
injecting patients with 10 ml of diluted adrenaline
1: 100 000 or 1: 200 000 into the nasal septal
submucoperichondrial plane mixed with 1% of
lidocaine. Inclusion criteria are either patients who
were not known to have any medical illnesses or
with known medical illness, for example, thyroid
disease, renal disease, hypersensitivity, cardiovascular
disease, hypertension, and using any medications with
cardiovascular adverse effects. Exclusion criteria are
patients whose ages less than 17 years old, combined
with other surgery like rhinoplasty or sinus surgery, and
who had hypersensitivity to injected adrenaline. Data
were collected using a premade collection sheet from
the electronic system. Data collection included patients’
demographics, BMI, oxygen saturation (SpO2),
comorbidities, heart rate, blood pressure, mean
arterial pressure, and arterial SpO2 using finger probe
pulse oximeter. Readings of patients’ parameters of
hemodynamics were taken after patient intubation
as a baseline and then every minute following local
injection till 12 min, as any hemodynamic changes
will appear during this period.
Statistical analysis

Statistical
analysis
was
performed
using
Statistical Package for Social Science software ,
version 21.0 (IBM Corp, Armok, NY, USA). Mean
and the SD was used to represent quantitative variables,
whereas number and percentage were used to represent
qualitative variables.

were estimated at two points: after intubation as the
baseline, and after injection for 12 min, as shown in
Table 2. Regarding heart rate, the baseline heart rate
ranged from 78 to 99, with a mean ± SD of 86.8 ± 6.4,
whereas the heart rate decreased to 75–99, with a
mean ± SD of 84.6 ± 6.5, at 12 min of injection, with
P value of 0.00. Regarding systolic blood pressure,
the baseline reading ranged from 77 to 111, with a
Table 1 Demographics and comorbidities of patients
Variables

Patients (n=223)

Nationality
Saudi
Non‑Saudi
Sex
Male
Female
Age
Mean±SD
Median (IQR)
Weight (kg)
Mean±SD
Median (IQR)
Height (cm)
Mean±SD
Median (IQR)
BMI
Mean±SD
Median (IQR)
Comorbidities
DM
HTN
Cardiac diseases
Hypothyroidism
Renal disease

197 (88.3)
26 (11.7)
162 (72.6)
61 (27.4)
30.70±29.00
9.32 (15-60)
71.16±13.95
70.00 (50-100)
1.63±0.08
1.60 (1.5-1.8)
26.84±5.76
26.56 (16.97-44.00)
43
39
8
4
5

Hypersensitivity for medication

Results
The present study included 223 patients, and
the majority of them were Saudi [197 (88.3%)].
The prevalence of males was more than
females [162 (72.6%) vs. 61 (27.4%), respectively].
The age range of patients was 17–60 years, with a
mean ± SD of 30.7 ± 9.3 years. The range of BMI
was 17–44, with a mean ± SD of 26.8 ± 5.8; those
with normal weight were more prevalent than other
weight groups [94 (42.2%)]. Regarding comorbidities,
43 (19.3%) patients had diabetes mellitus, 39 (17.5%)
had hypertension, eight (3.6%) only had cardiac
diseases, four (1.8%) had hypothyroidism, five (2.2%)
had renal disease, and 19 (8.5%) had hypersensitivity
for medications (e.g. ibuprofen). Details of patients’
demographics and comorbidities are shown in Table 1.
The mean hemodynamic parameters, such as heart
rate, systolic blood pressure, diastolic blood pressure,
mean arterial pressure, and peripheral capillary SpO2,
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(19.3)
(17.5)
(3.6)
(1.8)
(2.2)

35 (15.7)

n (%) represented the categorical variables, whereas mean±SD
represented numerical variables. DM, diabetes mellitus;
HTN, hypertension; IQR, interquartile range.
Table 2 Comparison of hemodynamics parameters between
baseline and fourth 3 min of reading
Variables
HR

SBP

DBP

MAP

SPO2 3 min

Mean±SD (median)
HR after intubation
86.78±6.43
85 (78-99)
SBP baseline
91.44±9.31
90 (77-111)
DBP baseline
68.15±4.38
70 (60-76)
MAP baseline
75.91±4.52
75.66 (66.67-84.33)
SpO2 baseline
99.50±0.50

HR 12 min
84.61±6.53
82 (75-99)
SBP 12 min
87.28±10.64
83 (74-111)
DBP 12 min
66.32±5.05
65 (60-75)
MAP 12 min
73.30±5.44
72.66 (64.67-87)
SpO2 12 min
99.50±0.50

100 (99-100)

99 (99-100)

P
0.00

0.00

0.00

0.00

0.94

DBP, diastolic blood pressure; HR; heart rate; MAP, mean arterial
pressure; SBP, systolic blood pressure; SpO2, oxygen saturation
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mean ± SD of 91.4 ± 9.3, and at 12 min, it became
74–111, with a mean ± SD of 87.3 ± 10.6. The range
and mean ± SD of diastolic blood pressure at baseline
and at 12 min were 60–76, with a mean ± SD of
68.2 ± 4.4, and 60–75, with a mean ± SD of 66.3 ± 5.1,
respectively. The P value was 0.00 for both systolic
and diastolic blood pressure. However, the mean
arterial pressure at baseline was 66.7–84.3, with a
mean ± SD of 75.9 ± 4.5, and at 12 min after injection
was 64.7–87, with a mean ± SD of 73.3 ± 5.4, with a
P value of 0.00. The range and mean ± SD of SpO2
were 99–100 and 99.5 ± 0.5, respectively, at baseline
reading, and 99–100 and 99.5 ± 0.5 at 12 min, with
P value of 0.94. The changes in the previous parameters
were investigated (Table 2). There were no statistically
significant differences regarding the increase of the
hemodynamic parameters including the mean heart
rate, systolic blood pressure, mean arterial pressure, and
SpO2 when comparison was done between the baseline
reading and after injection for the total 12 min.
However, we also did a comparison between
recorded parameters in relation to the comorbidity
status of the patients, and there were no significant
statistical differences between comorbid and
noncomorbid patients in different hemodynamic
parameters (Table 3). Finally, there was no increase
in all collected parameters after infiltration even with
general patient health status.

Discussion
A good visual field is the key factor to achieve a
successful and safe nasal surgery. It can be optimized
by many measurements, such as elevating the head of
Table 3 Comparison of hemodynamics regarding comorbidity
Variables
HR

SBP

DBP

MAP

SPO2

Mean±SD (median)
HR baseline
86.78±6.43
85 (78-99)
SBP baseline
91.44±9.31
90 (77-111)
DBP baseline
68.15±4.38
70 (60-76)
MAP baseline
75.91±4.52
75.66 (66.67-84.33)
SpO2 after induction
99.50±0.50

HR 12 min
84.61±6.53
82 (75-99)
SBP 12 min
87.28±10.64
83 (74-111)
DBP 12 min
66.32±5.05
65 (60-75)
MAP 12 min
73.30±5.44
72.66 (64.67-87)
SpO2 12 min
99.50±0.50

100 (99-100)

99 (99-100)

P
0.00

0.00

0.00

0.00

0.94

Comorbid patients are those having any disease or obese, overlap
may occur in some patients. DBP, diastolic blood pressure;
HR, heart rate; MAP, mean arterial pressure; SBP, systolic blood
pressure; SpO2, oxygen saturation.

the bed, anesthetic hypotension technique, injecting
vasoconstrictor agent, or applying various topical
medications including phenylephrine, cocaine,
oxymetazoline, and epinephrine [5]. However, during
such surgical procedure, general anesthesia and some
local anesthetics cause hyperemia of local (nasal)
mucosa and a bloody surgical field as a manifestation of
vasodilating effect, which advocates the need for using
topical vasoconstrictors in addition to local anesthetics
to reduce nasal blood flow [6]. Using concentrated
epinephrine either as a topical or submucosal injection
is widely used by otorhinolaryngologists in endoscopic
sinonasal surgery, as it is considered a powerful
nonselective alpha‑agonist because of its arteriolar and
venous sinusoidal constrictions. Moreover, the risk of
systemic effects such as arrhythmia and hypertension
is increased by perioperative use of volatile anesthetic
agents, which increase the myocardial sensitization
to the effects of epinephrine [7]. Knowing there
is no agreement regarding what is the appropriate
topical vasoconstrictor used in nasal surgery
regardless this fact [7]. Vasoconstrictors agents
were applied conventionally either by injection
or topically [8]. Overall, good visualization is a
key factor in preventing complications related to
sinonasal surgeries and achieving a good functional
nasal airway. Complications that may occur include
bleeding; cerebrospinal fluid rhinorrhea; extraocular
muscle damage; wound infection; septal abscess;
toxic shock syndrome; septal perforation; saddle nose
deformity; nasal tip depression; and sensory changes,
such as anosmia or dental anesthesia [9]. However, the
infiltration of epinephrine concentration of 1: 10 000–
1: 20 000 solutions is commonly used for topical
applications [10,11]. Besides, one study showed that
topical and injection of epinephrine (adrenaline)
resulted in a similar hemostatic effect in endoscopic
sinus surgery [8]. Epinephrine is a hormone released
from the adrenal medulla in response to stress, mediated
by sympathetic fibers. It is also called adrenaline,
derived from the name of its gland [12]. It stimulates
both alpha‑adrenergic and beta‑adrenergic systems;
causes systemic vasoconstriction, gastrointestinal
relaxation, and bronchodilation; and dilates the
cerebral vessels [13]. Alternative medications, such
as common nasal decongestants can be used as
topical vasoconstrictors, including phenylephrine
(alpha‑1 agonist) and oxymetazoline (alpha‑1
agonist and partial alpha‑2 agonist), but both have
lower affinity for alpha receptors in comparison with
adrenaline [7]. In addition, cocaine has a unique effect,
which provides both analgesia and vasoconstriction
effect, and unfortunately has a higher risk of
perioperative cardiac complication especially on the
elderly population [14]. Recently, a systemic review
suggested the efficacy and the safety of using topical
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epinephrine in endoscopic sinus surgery, which lowers
the overall complications rate, despite that the cardiac
complications were the most commonly reported in
patients with a history of cardiac disease [5]. In the
present study, we aim to confirm that using diluted
adrenaline injection during septoplasty is safe
regardless of the patients’ comorbidities. We found
that regarding heart rate, systolic blood pressure,
diastolic blood pressure, mean arterial pressure,
and SpO2, the mean baseline parameters were not
significantly changed after injection, without any
increase. Furthermore, many studies suggested that
associated cardiovascular complications with the
application of topical high‑concentrated epinephrine
1: 1000 to 1: 2000 doses are rare. Nonetheless, strict
handling protocols are required to prevent erroneous
preparation, which is a major contributing factor
to reported adverse events [5,7]. In contrast to our
findings, the study by Moshaver et al. [4] conducted on
patients performing endoscopic sinus surgery injected
with lidocaine 2% and 1: 100 000 adrenaline showed
an increase in the heart rate, systolic and diastolic
blood pressure, as well as mean arterial pressure.
The increase was found to be significant in the first
and second minutes after injection and decreased to
the baseline by the fifth minute. A study suggested
that the use of combined greater palatine canal and
transnasal injection of lidocaine and epinephrine is a
safe and effective method for reducing bleeding during
septoplasty. Moreover, they found that no significant
differences were observed in systolic and diastolic blood
pressure, heart rate, and mean arterial pressure of study
participants [3]. Another study found that 1% lidocaine
combined with 1: 200 000 or 1: 400 000 adrenaline
resulted in optimal hemostasis, but a concentration of
1: 800 000 led to significant lower vasoconstriction
effects [15]. The study by Alkhaldi et al. [16] compared
the use of three different concentrations of adrenaline
with submucosal infiltration in patients undergoing
septorhinoplasty; the study reported that the heart rate
was increased, mean arterial pressure was significantly
reduced, and systolic blood pressure was decreased.
Another study was designed to observe hemodynamic
changes caused by epinephrine‑containing lidocaine
solution in neurosurgical procedures and suggested
that the infiltration of epinephrine elicits temporary
but significant hemodynamic changes including
hypotension before craniotomy [17]. However,
another study [2] reported that the application of
topical adrenaline of 1: 10 000 concentrations showed
no significant hemodynamic effect, and there was
no protective effect for intraoperative blood loss.
Moreover, the authors suggested that the use of
adrenaline infiltration during septoplasty was not
necessary. The result of the present study showed no
increase in all parameters, with mild decreases in some
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parameters, including the heart rate, which is contrary
to what has been reported before, and these could
be related to the effect of the anesthesia medication
during induction. Moreover, no related complications
were reported, which was mostly owing to obtaining
a good satisfactory surgical field during the procedure,
and none of the patients needed any intraoperative
blood transfusion. However, further similar studies
might be needed to support the results. In general,
results of the different studies are controversial. The
differences between the studies may be owing to the
type of surgery, concentration adrenaline used, its
method of application and the site of its application,
the protocol of each study, and the patients’ clinical
characteristics.

Conclusion
The present study showed that injection of 10 ml of
diluted adrenaline (1:100000 or 1:200000) in the
sub-mucoperichondrial plane for patients undergoing
septoplasty is safe as there was no statistically
significant increase in the heart rate, systolic and
diastolic blood pressure and mean arterial pressure,
with stable hemodynamic parameters despite the
patient comorbidity.
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